Detalles de la búsqueda
1.
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
BMC Med;
22(1): 9, 2024 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191387
2.
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Mod Pathol;
36(1): 100009, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788064
3.
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Eur J Cancer;
195: 113401, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37925965
4.
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.
J Clin Oncol;
40(21): 2361-2374, 2022 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353548
5.
Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features.
BMC Cancer;
9: 175, 2009 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19505343
6.
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.
BMJ Open;
7(11): e017842, 2017 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29138205
7.
Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer.
Breast Cancer Res Treat;
104(1): 103-7, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17061043
8.
Low levels of BNIP3 promoter hypermethylation in invasive breast cancer.
Anal Cell Pathol (Amst);
33(3): 175-6, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20978322
Resultados
1 -
8
de 8
1
Próxima >
>>